One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation―The REIWA Region …

M Ishida, R Shimada, F Takahashi, M Niiyama… - Circulation …, 2024 - jstage.jst.go.jp
Background: The safety and feasibility of using 1-month dual antiplatelet therapy (DAPT)
followed by P2Y 12 inhibitor monotherapy for patients after percutaneous coronary …
被引用次数：2 相关文章

One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation - The REIWA Region …

M Ishida, R Shimada, F Takahashi… - … : Official Journal of the …, 2024 - europepmc.org
Background The safety and feasibility of using 1-month dual antiplatelet therapy (DAPT)
followed by P2Y 12 inhibitor monotherapy for patients after percutaneous coronary …

One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region …

I Masaru, S Ryutaro, T Fumiaki, N Masanobu… - Circulation …, 2024 - cir.nii.ac.jp
抄録< p> Background: The safety and feasibility of using 1-month dual antiplatelet therapy
(DAPT) followed by P2Y 12 inhibitor monotherapy for patients after percutaneous coronary …

One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation―The REIWA Region …

M Ishida, R Shimada, F Takahashi, M Niiyama… - Circulation …, 2024 - jstage.jst.go.jp
Background: The safety and feasibility of using 1-month dual antiplatelet therapy (DAPT)
followed by P2Y 12 inhibitor monotherapy for patients after percutaneous coronary …

One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation-The REIWA Region …

M Ishida, R Shimada, F Takahashi… - … : official journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
Background The safety and feasibility of using 1-month dual antiplatelet therapy (DAPT)
followed by P2Y 12 inhibitor monotherapy for patients after percutaneous coronary …

One-Month Dual Antiplatelet Therapy Followed by P2Y12 Inhibitor Monotherapy After Biodegradable Polymer Drug-Eluting Stent Implantation ― The REIWA Region …

I Masaru, S Ryutaro, T Fumiaki, N Masanobu… - Circulation …, 2024 - cir.nii.ac.jp
抄録< p> Background: The safety and feasibility of using 1-month dual antiplatelet therapy
(DAPT) followed by P2Y 12 inhibitor monotherapy for patients after percutaneous coronary …